Clinical Trial Update: A Comparative Phase IV Study Evaluating Efficacy & Safety Of Magnex(Cefoperazone-Sulbactam) In Intraabdominal Infections [Phase 4]

View source ↗

Summary

A Phase IV trial evaluating Magnex (cefoperazone-sulbactam) for intra-abdominal infection has completed, with the document serving as a status update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intra-abdominal Infection

Drugs mentioned

• Magnex (cefoperazone-sulbactam)

Snippet

Sponsor: Pfizer | Conditions: Infection | Phase 4 | Status: COMPLETED